NiKem Research receives certification for GLP Bioanalysis
NiKem Research has provided for many years bioanalytical support both for its in vitro ADME(T) and in vivo PK services associated to various drug discovery programs and as a standalone capability. The company is now able to offer bioanalysis as a GLP service to support clients preclinical PK and toxicology studies.
Giuseppe Giardina, CEO & Managing Director of NiKem, said “This new product is an important step in NiKem’s continuing expansion of its high quality, cost effective services to support progression of our clients’ drug discovery programmes”.
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.